Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Melinta Therapeutics logo — Unparalleled in Passion & Purpose

Melinta Therapeutics

Unparalleled in Passion & Purpose

Founded 2000 United States United States 156 employees Post Ipo Equity Total: $877.40M Biotechnology, Health Care +1

General Information

Company Name Melinta Therapeutics
Founded Year 2000
Location United States United States +2
Employees 156
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Melinta Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Melinta Therapeutics

Melinta Therapeutics is a biotechnology company that prides itself on being unparalleled in passion and purpose. The company's high touch and big impact approach sets it apart, with a focus on agility and dedication to adding value at every turn. Melinta's culture is built on tenacity, brilliance, resilience, excellence, and courage, showcasing an unwavering resolve and a commitment to taking responsibilities seriously. Founded in 2000, the company operates in the biotechnology, health care, and pharmaceutical industries, with its headquarters located in the United States. Its last investment amounted to $123.20M in Post-IPO Equity, secured on 30 May 2018. Melinta is poised for significant growth, aiming to meet the unmet needs of patients collaboratively and believes in the power of diverse teams for meaningful impact. This company is one to watch, as it strives to make legendary strides in its field, recognizing that every step counts.

Taxonomy: pharmaceuticals, antibiotics, drug development, infectious diseases, public health, drug-resistant infections, clinical trials, investor-backed, life sciences, healthcare startups, acute care, patient-centered care

Funding Rounds & Investors (14)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 30 May 2018
Grant •••••• 1
Investor
07 May 2018
Post-IPO Debt •••••• 1 •••• •••• 29 Nov 2017
Post-IPO Equity •••••• 1
Investor
29 Jun 2017
Post-IPO Equity •••••• 2
Investor
•••• •••• 		10 Jun 2015

View All 14 Funding Rounds

Melinta Therapeutics Alternatives & Competitors

Melinta Therapeutics vs
Log my Care
Log my Care United Kingdom

Transforming care for society's most vulnerable people.

Series A
44 employees
Digital Health, Internet
Compare Melinta Therapeutics vs Log my Care
Melinta Therapeutics vs
NOLEO
NOLEO United States

WE STAND AGAINST TOXIC

Seed
7 employees
Consumer Goods, Food and Beverage
Compare Melinta Therapeutics vs NOLEO
Melinta Therapeutics vs
Cadia Healthcare
Cadia Healthcare United States

The Best Place to Get Better.

403 employees
Health Care
Also compare with: Melinta Therapeutics vs MAX Solutions MAX Solutions

FAQ About Melinta Therapeutics

Unparalleled in Passion & Purpose
Melinta Therapeutics was founded in 2000.
Melinta Therapeutics is headquartered in United States.
Melinta Therapeutics operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Melinta Therapeutics has approximately 156 employees.
Melinta Therapeutics has completed 14 funding rounds, raising a total of $877.40M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Melinta Therapeutics include Log my Care, NOLEO, Cadia Healthcare, MAX Solutions, Slick Chicks. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Melinta Therapeutics and Log my Care are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Melinta Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy